Hui, R., Pearson, A., Cortes Castan, J., Campbell, C., Poirot, C., Azim, H. A., Fumagalli, D., Lambertini, M., Daly, F., Arahmani, A., Perez-Garcia, J., Aftimos, P. G., Bedard, P., Xuereb, L., Loibl, S., Loi, S., Pierrat, M., Turner, N. C., André, F., & Curigliano, G. (n.d.). 289PDLucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095475785.0x000035